Benefits of oral Polypodium Leucotomos extract in MM high-risk patients von Aguilera, P., Carrera, C., Puig-Butille, J.A., Badenas, C., Lecha, M., González, S., Malvehy, J., Puig, S.

Volltext

POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families von Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

Volltext

Mutational status of naevus-associated melanomas von Shitara, D., Tell-Martí, G., Badenas, C., Enokihara, M.M.S.S., Alós, L., Larque, A.B., Michalany, N., Puig-Butille, J.A., Carrera, C., Malvehy, J., Puig, S., Bagatin, E.

Volltext

Discrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authors von Shitara, D., Tell-Martí, G., Badenas, C., Enokihara, M.M.S.S., Alós, L., Larque, A.B., Michalany, N., Puig-Butille, J.A., Carrera, C., Malvehy, J., Puig, S., Bagatin, E.

Volltext

Genetic variations of patients with familial or multiple melanoma in Southern Brazil von Grazziotin, T.C., Rey, M.C.W., Bica, C.G., Pinto, L.A., Bonamigo, R.R., Puig-Butille, J.A., Cuellar, F., Puig, S.

Volltext

Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes von Antúnez‐Lay, A., Podlipnik, S., Carrera, C., Potrony, M., Tell‐Martí, G., Badenas, C., Puig‐Butille, J.A., Espinosa, N., Puig, S., Malvehy, J.

Volltext

Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma von Pozzobon, F.C., Puig-Butillé, J.A., González-Alvarez, T., Carrera, C., Aguilera, P., Alos, L., Badenas, C., Grichnik, J.M., Malvehy, J., Puig, S.

Volltext

Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status von Bombonato, C., Ribero, S., Pozzobon, F.C., Puig‐Butille, J.A., Badenas, C., Carrera, C., Malvehy, J., Moscarella, E., Lallas, A., Piana, S., Puig, S., Argenziano, G., Longo, C.

Volltext

Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF von Mangas, C., Potrony, M., Mainetti, C., Bianchi, E., Carrozza Merlani, P., Mancarella Eberhardt, A., Maspoli-Postizzi, E., Marazza, G., Marcollo-Pini, A., Pelloni, F., Sessa, C., Simona, B., Puig-Butillé, J.A., Badenas, C., Puig, S.

Volltext

POT1 and TERT promoter molecular screening in Spanish melanoma families von Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

Volltext

Mutation of the tumour suppressor p33ING1b is rare in melanoma von Stark, M., Puig-Butille, J.A., Walker, G., Badenas, C., Malvehy, J., Hayward, N., Puig, S.

Volltext

Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population von Puig-Butillé, J.A., Carrera, C., Kumar, R., Garcia-Casado, Z., Badenas, C., Aguilera, P., Malvehy, J., Nagore, E., Puig, S.

Volltext

140MO HER2DX genomic test in HER2-positive/hormone receptor-positive (HER2+/HR+) breast cancer (BC) treated with neoadjuvant trastuzumab (T) and pertuzumab (P): A correlative analy... von Guarneri, V., Dieci, M.V., Griguolo, G., Pare Brunet, L., Marin, M., Miglietta, F., Bottosso, M., Giorgi, C.A., Blasco, P., Castillo, O., Galván, P., Jares, P., Puig-butille, J.A., Vivancos, A., Villagrasa Gonzalez, P., Parker, J., Perou, C.M., Conte, P.F., Prat, A.

Volltext

263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (... von Rodriguez Hernandez, A., Martinez Saez, O., Brasó-Maristany, F., Pastor, B., Potrony, M., Moreno, L., Grau, E., Puig-Butille, J.A., Sánchez, A., Schettini, F., Conte, B., Chic, N., Vidal Losada, M.J., Munoz, M., Balaguer, F., Prat, A., Adamo, B.

Volltext

25P Research-based HER2DX in patients with early-stage HER2-positive (HER2+) breast cancer treated in the N9831 phase III clinical trial von Brasó-Maristany, F., Martinez Saez, O., Pare Brunet, L., Marín-Aguilera, M., Conte, P.F., Jares, P., Guarneri, V., Pascual, T., Puig-Butille, J.A., Vivancos, A., Parker, J., Villagrasa Gonzalez, P., Tolaney, S.M., Carey, L.A., Perou, C.M., Prat, A.

Volltext

147P Breast cancer in women with germline pathogenic variants: Frequency, clinical behavior, and outcomes of a consecutive series of patients from Spain von Rodriguez Hernandez, A., Braso Maristany, F., Pastor, B., Potrony, M., Moreno, L., Grau, E., Puig-Butille, J.A., Martinez Saez, O., Conte, B., Chic, N., Vidal Losada, M.J., Munoz, M., Balaguer, F., Prat, A., Adamo, B.

Volltext

在一组西班牙黑色素瘤家族中,与黑色素瘤易感性有关的是 POT1 生殖系突变而非 TERT 启动子突变 von Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

Volltext

CDKN2A mutations in melanoma families from Uruguay von Borges, A.L., Cuéllar, F., Puig-Butillé, J.A., Scarone, M., Delgado, L., Badenas, C., Milà, M., Malvehy, J., Barquet, V., Núñez, J., Laporte, M., Fernández, G., Levrero, P., Martínez-Asuaga, M., Puig, S.

Volltext

1366P - Evaluating polygenic risk score prediction model for melanoma prognosis von Potrony, M., Calbet-llopart, N., Combalia, M., Tell-Martí, G., Puig-Butille, J.A., Barreiro, A., Podlipnik, S., Carrera, C., Malvehy, J., Puig, S.

Volltext

Evaluating polygenic risk score prediction model for melanoma prognosis von Potrony, M., Calbet-llopart, N., Combalia, M., Tell-Martí, G., Puig-Butille, J.A., Barreiro, A., Podlipnik, S., Carrera, C., Malvehy, J., Puig, S.

Volltext